Cadence Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-32,094
Closed -$565K – 644
2016
Q1
$565K Buy
32,094
+2,494
+8% +$37.2K 0.04% 451
2015
Q4
$446K Buy
29,600
+6,280
+27% +$96.6K 0.03% 490
2015
Q3
$306K Buy
+23,320
New +$370K 0.02% 525
2015
Q2
– Sell
-33,665
Closed -$632K – 652
2015
Q1
$632K Buy
33,665
+8,395
+33% +$144K 0.04% 470
2014
Q4
$419K Buy
+25,270
New +$533K 0.02% 523

Other funds holding PTEN

Cadence Capital Management's PTEN Position: Q2 2016 in Review

Cadence Capital Management sold out of Patterson-UTI (PTEN) in Q2 2016, closing a stake of 32,094 shares — an estimated $565K sold.

Cadence Capital Management first reported a position in PTEN in Q4 2014 and held it in 5 quarters. The position peaked at $632K in Q1 2015. 287 funds tracked by Wall St. Rank hold PTEN as of Q2 2016.

  • Cadence Capital Management reported no remaining Patterson-UTI position as of Q2 2016 after selling out during the quarter.
  • Cadence Capital Management sold 32,094 Patterson-UTI shares in Q2 2016, an estimated $565K.
  • Cadence Capital Management first reported a position in Patterson-UTI in Q4 2014 and held it in 5 quarters.
  • Cadence Capital Management's Patterson-UTI position peaked at $632K in Q1 2015.
  • 287 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2016.

Based on Cadence Capital Management's 13F filing for Q2 2016, filed 3 Aug 2016.